Bioequivalence of Combination Products: Special Testing Challenges Explained
Bioequivalence testing for combination products like fixed-dose pills, topical creams, and inhalers is far more complex than for single-drug generics. Learn why these drugs are harder to copy, how regulators are responding, and what it means for patient access and costs.
CONTINUE